A new study published in Brain Communications has uncovered abnormal brain wave activity in individuals with Alzheimer’s ...

Eli Lilly and AstraZeneca’s late-stage Alzheimer’s drug is to get faster development ... inhibitor is to get a Fast Track review, where the US Food and Drug Administration expedites ...

This approach significantly improves survival of human neurons exposed to disease-related proteins, suggesting potential for early intervention in neurodegenerative diseases such as Alzheimer's ...

Kaylee Strachan of the Alzheimer Society of Calgary and Eleanor Finger of Dementia Network Calgary attend an event at the Calgary Central Library on Wednesday, April 23, 2025.

Having a loved one diagnosed with Alzheimer’s can feel devastating and overwhelming, and it profoundly impacts the individual’s financial stability, as well as their family and caregivers.

“We are encouraged by the FDA’s Fast Track designation for BIIB080, which highlights the urgent need for innovative treatments targeting tau pathology in Alzheimer’s disease,” said Priya Singhal, M.D.

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) — Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an ...